These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32982112)

  • 1. Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis
    Fernández-Ramos D; Lopitz-Otsoa F; Delacruz-Villar L; Bilbao J; Pagano M; Mosca L; Bizkarguenaga M; Serrano-Macia M; Azkargorta M; Iruarrizaga-Lejarreta M; Sot J; Tsvirkun D; van Liempd SM; Goni FM; Alonso C; Martínez-Chantar ML; Elortza F; Hayardeny L; Lu SC; Mato JM
    World J Gastroenterol; 2020 Sep; 26(34):5101-5117. PubMed ID: 32982112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Aramchol in steatohepatitis and fibrosis in mice.
    Iruarrizaga-Lejarreta M; Varela-Rey M; Fernández-Ramos D; Martínez-Arranz I; Delgado TC; Simon J; Juan VG; delaCruz-Villar L; Azkargorta M; Lavin JL; Mayo R; Van Liempd SM; Aurrekoetxea I; Buqué X; Cave DD; Peña A; Rodríguez-Cuesta J; Aransay AM; Elortza F; Falcón-Pérez JM; Aspichueta P; Hayardeny L; Noureddin M; Sanyal AJ; Alonso C; Anguita J; Martínez-Chantar ML; Lu SC; Mato JM
    Hepatol Commun; 2017 Nov; 1(9):911-927. PubMed ID: 29159325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis.
    Bhattacharya D; Basta B; Mato JM; Craig A; Fernández-Ramos D; Lopitz-Otsoa F; Tsvirkun D; Hayardeny L; Chandar V; Schwartz RE; Villanueva A; Friedman SL
    JHEP Rep; 2021 Jun; 3(3):100237. PubMed ID: 34151243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease.
    Safadi R; Konikoff FM; Mahamid M; Zelber-Sagi S; Halpern M; Gilat T; Oren R;
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2085-91.e1. PubMed ID: 24815326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial.
    Ratziu V; de Guevara L; Safadi R; Poordad F; Fuster F; Flores-Figueroa J; Arrese M; Fracanzani AL; Ben Bashat D; Lackner K; Gorfine T; Kadosh S; Oren R; Halperin M; Hayardeny L; Loomba R; Friedman S; ; Sanyal AJ
    Nat Med; 2021 Oct; 27(10):1825-1835. PubMed ID: 34621052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
    Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
    Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
    Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
    He Q; Sha S; Sun L; Zhang J; Dong M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
    Kim M; Yoo G; Randy A; Kim HS; Nho CW
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.
    Zhang M; Zhao Y; Li Z; Wang C
    Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
    Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
    J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet.
    Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ
    J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vine tea total flavonoids activate the AMPK/mTOR pathway to amelioration hepatic steatosis in mice fed a high-fat diet.
    Wang C; Yang F; Zeng W; Chen X; Qiu Z; Wang Q; Meng Y; Zheng G; Hu J
    J Food Sci; 2024 May; 89(5):3019-3036. PubMed ID: 38517018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
    Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
    Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathway.
    Wu C; Jing M; Yang L; Jin L; Ding Y; Lu J; Cao Q; Jiang Y
    Chem Biol Interact; 2018 Aug; 291():111-119. PubMed ID: 29883724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.